AMANDA BROCK: Open Payments
NPI 1063121689 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 36 payments from 13 companies in 2025. Trend: 2023 $520 · 2024 $1,039 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $234 |
| ABBVIE INC. | 4 | $168 |
| Edwards Lifesciences Corporation | 1 | $167 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $144 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Lilly USA, LLC | 3 | $70 |
| Novo Nordisk Inc | 2 | $39 |
| Amgen Inc. | 2 | $28 |
| PFIZER INC. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), QULIPTA, FARXIGA, AIRSUPRA, OFEV, LEQVIO, JARDIANCE, BREZTRI.
Industry payments across FL — which companies pay providers there.
